Eli Lilly & Co: Jivraj Sanjay

Eli Lilly & Co has received mixed feedback from users regarding their diabetes medications, particularly Mounjaro and Trulicity. While some patients have reported positive experiences with Mounjaro in managing their blood sugar levels, others express frustration over inconsistent availability and production issues that affect their treatment. Overall, there is a strong desire for the company to prioritize patient needs and improve access to their essential medications.